Literature DB >> 28942120

Immobilization-induced osteolysis and recovery in neuropathic foot impairments.

David R Sinacore1, Mary K Hastings2, Kathryn L Bohnert3, Michael J Strube4, David J Gutekunst5, Jeffrey E Johnson6.   

Abstract

BACKGROUND: Neuropathic foot impairments treated with immobilization and off-loading result in osteolysis. In order to prescribe and optimize rehabilitation programs after immobilization we need to understand the magnitude of pedal osteolysis after immobilization and the time course for recovery.
OBJECTIVE: To determine differences in a) foot skin temperature; b) calcaneal bone mineral density (BMD) after immobilization; c) calcaneal BMD after 33-53weeks of recovery; and d) percent of feet classified as osteopenic or osteoporotic after recovery in participants with neuropathic plantar ulcers (NPU) compared to Charcot neuroarthropathy (CNA).
METHODS: Fifty-five participants with peripheral neuropathy were studied. Twenty-eight participants had NPU and 27 participants had CNA. Bilateral foot skin temperature was assessed before immobilization and bilateral calcaneal BMD was assessed before immobilization, after immobilization and after recovery using quantitative ultrasonometry.
RESULTS: Before immobilization, skin temperature differences in CNA between their index and contralateral foot were markedly higher than NPU feet (3.0 degree C versus 0.7 degree C, respectively, p<0.01); BMD in NPU immobilized feet averaged 486±136mg/cm2, and CNA immobilized feet averaged 456±138mg/cm2, p>0.05). After immobilization, index NPU feet lost 27mg/cm2; CNA feet lost 47mg/cm2 of BMD, p<0.05. After recovery, 61% of NPU index feet and 84% of CNA index feet were classified as osteopenic or osteoporotic.
CONCLUSIONS: There was a greater osteolysis after immobilization with an attenuated recovery in CNA feet compared to NPU feet. The attenuated recovery of pedal BMD in CNA feet resulted in a greater percentage of feet classified as osteoporotic and osteopenic.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone loss; Neuropathic (Charcot) osteoarthropathy; Neuropathic plantar ulcers; Quantitative ultrasonometry; Total contact casting

Mesh:

Year:  2017        PMID: 28942120      PMCID: PMC5650927          DOI: 10.1016/j.bone.2017.09.009

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  37 in total

1.  Response of Charcot's arthropathy to contact casting: assessment by quantitative techniques.

Authors:  M McGill; L Molyneaux; T Bolton; K Ioannou; R Uren; D K Yue
Journal:  Diabetologia       Date:  2000-04       Impact factor: 10.122

2.  Inflammatory osteolysis in diabetic neuropathic (charcot) arthropathies of the foot.

Authors:  David R Sinacore; Mary K Hastings; Kathryn L Bohnert; Faye A Fielder; Dennis T Villareal; Vilray P Blair; Jeffrey E Johnson
Journal:  Phys Ther       Date:  2008-09-18

3.  Effect of immobilization, off-loading and zoledronic acid on bone mineral density in patients with acute Charcot neuroarthropathy: a prospective randomized trial.

Authors:  Toni-Karri Pakarinen; Heikki-Jussi Laine; Heikki Mäenpää; Mika Kähönen; Pentti Mattila; Jorma Lahtela
Journal:  Foot Ankle Surg       Date:  2013-02-20       Impact factor: 2.705

4.  Reliability of a diabetic foot evaluation.

Authors:  J E Diamond; M J Mueller; A Delitto; D R Sinacore
Journal:  Phys Ther       Date:  1989-10

Review 5.  Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle.

Authors:  D R Sinacore; N C Withrington
Journal:  J Orthop Sports Phys Ther       Date:  1999-12       Impact factor: 4.751

6.  The dysvascular foot: a system for diagnosis and treatment.

Authors:  F W Wagner
Journal:  Foot Ankle       Date:  1981-09

7.  Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.

Authors:  D G Armstrong; L A Lavery; S A Vela; T L Quebedeaux; J G Fleischli
Journal:  Arch Intern Med       Date:  1998-02-09

8.  Persistent inflammation with pedal osteolysis 1year after Charcot neuropathic osteoarthropathy.

Authors:  David R Sinacore; Kathryn L Bohnert; Kirk E Smith; Mary K Hastings; Paul K Commean; David J Gutekunst; Jeffrey E Johnson; Fred W Prior
Journal:  J Diabetes Complications       Date:  2017-02-14       Impact factor: 2.852

Review 9.  Role of neuropathy on fracture healing in Charcot neuro-osteoarthropathy.

Authors:  G Mabilleau; M E Edmonds
Journal:  J Musculoskelet Neuronal Interact       Date:  2010-03       Impact factor: 2.041

10.  Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker.

Authors:  J M Morgan; W C Biehl; F W Wagner
Journal:  Clin Orthop Relat Res       Date:  1993-11       Impact factor: 4.176

View more
  1 in total

1.  Accelerated Cortical Osteolysis of Metatarsals in Charcot Neuroarthropathy: A Cross-Sectional Observational Study.

Authors:  David R Sinacore; Kirk E Smith; Kathryn L Bohnert; David J Gutekunst; Jeffrey E Johnson; Michael J Strube
Journal:  JBMR Plus       Date:  2019-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.